Abstract
The purpose of this talk is to briefly address some highlights about the illness and its burden in relation to travel, new epidemiological aspects, particularly focusing on the Caribbean and South American situation in 2008-9. Conceptual points regarding yellow fever vaccine will be reviewed, focusing specially on severe adverse events described in the last 10 years, which have put the actual vaccine risk/benefit relation under close scrutiny. Some practical situations regarding its indication that could lead to controversy will be also discussed. Abstracts for SupplementInternational Journal of Infectious DiseasesVol. 14Preview Full-Text PDF Open Archive
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
